市场调查报告书
商品编码
1084343
斑块切除设备的全球市场趋势和预测(2022-2028):按驱动器类型、应用、最终用户和地区Global Atherectomy Devices Market by Device Type, Application, End User and by Geography - Trends and Forecast, 2022 - 2028 |
旋切术是一种去除体内血管动脉硬化的医疗器械。动脉粥样硬化斑块切除术是血管成形术的替代疗法,广泛用于治疗由于外周动脉疾病引起的动脉狭窄。有四种类型的斑块切除术:有四种类型:定向旋磨术、旋磨术、激光旋磨术和眼眶旋磨术。
预计心血管疾病 (CVD) 患病率的增加将推动粥样斑块切除术的市场增长。根据欧洲心臟网络 (EHN) 2017 年发表的一篇文章,心血管疾病每年在欧洲造成约 390 万人死亡,在欧盟造成超过 180 万人死亡,约占欧洲所有死亡人数的 45%。占所有死亡人数的 37%。预计更多创新产品的推出和频繁的监管批准将推动斑块切除术设备市场的增长。 2018 年,Avinger Inc. 获得了下一代 Pantheris Lumivascular Atherectomy System 的 CE 标誌批准,这是一种用于治疗外周动脉疾病的图像引导的旋切术设备。预计新产品采用率的增加将推动全球粥样斑块切除设备市场的增长。
本报告调查世界市场,定义和概述市场,分析影响市场增长的各种影响因素、市场规模的变化/预测、各个类别/地区/主要国家的细分以及竞争。它总结了环境、概况大公司等
Atherectomy devices are the medical devices, which are used for removing atherosclerosis from blood vessels within the body. Atherectomy devices are alternative to angioplasty and widely used to treat narrowing in arteries caused by peripheral artery disease. There are four types of atherectomy namely: Directional atherectomy, Rotational atherectomy, Laser atherectomy, and Orbital atherectomy.
Increasing prevalence of cardiovascular diseases (CVD’s) is expected to drive growth of atherectomy devices market. According to article published in the European Heart Network (EHN) in 2017, CVD causes around 3.9 million deaths in Europe annually and over 1.8 million deaths in the European Union, which accounts for about 45% of all deaths in Europe and 37% of all deaths in the EU. Furthermore launches of innovative products and frequent approval of these devices from regulatory bodies is expected to drive growth of the atherectomy devices market. In 2018, Avinger Inc., received CE Marking approval for next-generation Pantheris Lumivascular atherectomy system, an image-guided atherectomy device for the treatment of Peripheral artery disease. Increasing adoption of novel product is expected to fuel growth of the global atherectomy devices market.
This report provides in-depth analysis of atherectomy devices market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global atherectomy devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
Key companies covered as a part of this study include Medtronic plc, Koninklijke Philips N.V., Cardiovascular Systems, Inc., Boston Scientific Corporation, Avinger, Inc, C. R. Bard, Inc, Cardinal Health, Inc., Minnetronix, Inc., Straub Medical AG, and Biotronik.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global atherectomy devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the atherectomy devices market
Global Atherectomy Devices Market, By Device Type:
Directional Atherectomy Devices
Rotational Atherectomy Devices
Orbital Atherectomy Devices
Laser Atherectomy Devices
Global Atherectomy Devices Market, By Application:
Cardiovascular
Neurovascular
Peripheral Vascular
Global Atherectomy Devices Market, By End User:
Hospital
Ambulatory Surgical Centers
Medical Institutes
Global Atherectomy Devices Market, By Region:
North America
By Product Type:
Directional Atherectomy Devices
Rotational Atherectomy Devices
Orbital Atherectomy Devices
Laser Atherectomy Devices
By Application:
Cardiovascular
Neurovascular
Peripheral Vascular
By End User:
Hospital
Ambulatory Surgical Centers
Medical Institutes
By Country:
U.S.
Canada
Europe
By Product Type:
Directional Atherectomy Devices
Rotational Atherectomy Devices
Orbital Atherectomy Devices
Laser Atherectomy Devices
By Application:
Cardiovascular
Neurovascular
Peripheral Vascular
By End User:
Hospital
Ambulatory Surgical Centers
Medical Institutes
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type:
Directional Atherectomy Devices
Rotational Atherectomy Devices
Orbital Atherectomy Devices
Laser Atherectomy Devices
By Application:
Cardiovascular
Neurovascular
Peripheral Vascular
By End User:
Hospital
Ambulatory Surgical Centers
Medical Institutes
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Product Type:
Directional Atherectomy Devices
Rotational Atherectomy Devices
Orbital Atherectomy Devices
Laser Atherectomy Devices
By Application:
Cardiovascular
Neurovascular
Peripheral Vascular
By End User:
Hospital
Ambulatory Surgical Centers
Medical Institutes
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
By Product Type:
Directional Atherectomy Devices
Rotational Atherectomy Devices
Orbital Atherectomy Devices
Laser Atherectomy Devices
By Application:
Cardiovascular
Neurovascular
Peripheral Vascular
By End User:
Hospital
Ambulatory Surgical Centers
Medical Institutes
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product Type:
Directional Atherectomy Devices
Rotational Atherectomy Devices
Orbital Atherectomy Devices
Laser Atherectomy Devices
By Application:
Cardiovascular
Neurovascular
Peripheral Vascular
By End User:
Hospital
Ambulatory Surgical Centers
Medical Institutes
By Country:
Central Africa
South Africa
North Africa
Company Profiles
Medtronic plc.*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Koninklijke Philips N.V.
Cardiovascular Systems, Inc.
Boston Scientific Corporation
Avinger, Inc.
R. Bard, Inc.
Cardinal Health, Inc.
Minnetronix, Inc.
Straub Medical AG
Biotronik
“*” marked represents similar segmentation in other categories in the respective section.